TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive In Brief: NCI Cutting Back Support For Training Medical, Pediatric Oncologists; Clark Receives ACS Award December 5, 1980
TCL Archive Dept. of Defense opens program announcements for prostate cancer research. December 10, 2004
